In this issue:
Efficacy of obicetrapib in patients at high cardiovascular risk
Benefits and risks of colchicine in patients with ASCVD
Add-on treatment with zilebesiran for inadequately controlled hypertension
Bedtime vs morning dosing of antihypertensive medications
Catheter ablation vs drug therapy in patients with AF
Age-stratified effect of rivaroxaban in patients with AF and stable CAD
Abbreviated vs prolonged DAPT in high bleeding risk patients after PCI
Projected global impact of fixed-dose combination therapies
Impact of BMI and weight loss on the benefits of tirzepatide in obesity-related HF
Dapagliflozin ± spironolactone in patients with HFpEF
Please login below to download this issue (PDF)